메뉴 건너뛰기
Chest
Volumn 129, Issue 1, 2006, Pages 5-6
COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: Time to look beyond the FEV1
Author keywords

[No Author keywords available]
Indexed keywords

BRONCHODILATING AGENT; CILOMILAST; CORTICOSTEROID; PHOSPHODIESTERASE IV INHIBITOR; ROFLUMILAST; THEOPHYLLINE;
EID: 33244465222     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.1.5     Document Type: Editorial
Times cited : (9)
References (9)
  • 1
    • 1842552109 scopus 로고    scopus 로고
    • Standards for the diagnosis and treatment of COPD
    • Celli BR, MacNee W. Standards for the diagnosis and treatment of COPD. Eur Respir J 2004; 23:932-946
    • (2004) Eur Respir J , vol.23 , pp. 932-946
    • Celli, B.R.1    MacNee, W.2
  • 2
    • 2942720573 scopus 로고    scopus 로고
    • The nature of small-airway obstruction in chronic obstructive pulmonary disease
    • Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004 24; 350:2645-2653
    • (2004) N Engl J Med , vol.350 , Issue.26 , pp. 2645-2653
    • Hogg, J.C.1    Chu, F.2    Utokaparch, S.3
  • 3
    • 0034130633 scopus 로고    scopus 로고
    • Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors
    • Souness J, Aldous D, Sargent C. Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology 2000; 47:127-162
    • (2000) Immunopharmacology , vol.47 , pp. 127-162
    • Souness, J.1    Aldous, D.2    Sargent, C.3
  • 4
    • 0035188826 scopus 로고    scopus 로고
    • Cyclic nucleotide phosphodiesterases
    • Essayan D. Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol 2001; 108:671-680
    • (2001) J Allergy Clin Immunol , vol.108 , pp. 671-680
    • Essayan, D.1
  • 5
    • 23744451716 scopus 로고    scopus 로고
    • Roflumilast: An oral anti-inflammatory treatment for chronic obstructive pulmonary disease: A randomized controlled trial
    • Rabe K, Bateman E, O'Donnell D, et al. Roflumilast: an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2005; 366:563-571
    • (2005) Lancet , vol.366 , pp. 563-571
    • Rabe, K.1    Bateman, E.2    O'Donnell, D.3
  • 6
    • 0030983708 scopus 로고    scopus 로고
    • Mortality by cause for eight regions of the world: Global Burden of Disease Study
    • Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349:1269-1276
    • (1997) Lancet , vol.349 , pp. 1269-1276
    • Murray, C.J.L.1    Lopez, A.D.2
  • 7
    • 0018885920 scopus 로고
    • Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease
    • Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 1980; 93:391-398
    • (1980) Ann Intern Med , vol.93 , pp. 391-398
  • 8
    • 0019460452 scopus 로고
    • Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema
    • Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1:681-686
    • (1981) Lancet , vol.1 , pp. 681-686

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.